The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Find out which Indian University was the first to teach biotechnology and why it was important for science and education in ...
The MarketWatch News Department was not involved in the creation of this content. The biotechnology market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing ...
Like other commissions set up by Congress—such as the Cyberspace Solarium Commission that provided crucial cybersecurity measures—the National Security Commission on Emerging Biotechnology (NSCEB) was ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results